11 Organizations Urge Caution, Not Ban, on CRISPR Germline Genome Editing

August 7, 2017

(Genetic Engineering & Biotechnology News) – One day after publication of a landmark study detailing the first-in-the-U.S. use of CRISPR (clustered regularly interspaced short palindromic repeats) to repair a germline mutation in human embryos created through in vitro fertilization, 11 genetics-focused professional organizations are calling for researchers to use caution in applying the technology. The 11 organizations have issued a policy statement stopping short of calling for a ban on human germline genome editing.

Recommended Reading